🇺🇸 FDA

Intelligence · Clinical Pipeline

Phase II Pipeline Programs

Proof-of-concept and dose-finding clinical programs in Phase II development.

Programs
7,238

Quick answer

NovaPharmaNews tracks 7,238 phase ii pharmaceutical pipeline programs from ClinicalTrials.gov. Proof-of-concept and dose-finding clinical programs in Phase II development.

Top sponsors

Page 137 of 151

  1. Vodobatinib (K0706) capsules

    Advanced Accelerator Applications

    Healthy (For Part A)

    phase 2 small molecule terminated

    1 trial

  2. Volixibat

    Mirum Pharmaceuticals International B.V.

    Primary Sclerosing Cholangitis

    phase 2 small molecule active

    1 trial

  3. Volixibat

    Mirum Pharmaceuticals International B.V.

    Primary Biliary Cholangitis

    phase 2 small molecule active

    1 trial

  4. Volixibat

    Mirum Pharmaceuticals International B.V.

    Intrahepatic Cholestasis of Pregnancy

    phase 2 small molecule terminated

    1 trial

  5. Volrustomig

    AstraZeneca

    Sub-study 1 Cervical Cancer (Volrustomig Monotherapy)

    phase 2 mab active

    1 trial

  6. Vonafexor

    Lacuna Pharma Pty Ltd

    Alport Syndrome

    phase 2 small molecule active

    1 trial

  7. Vonafexor, ROSUVASTATIN , IOHEXOL , Vonafexor

    Lacuna Pharma Pty Ltd

    Impaired renal function and suspected MASH

    phase 2 small molecule active

    1 trial

  8. Vonoprazan

    Takeda

    Gastroesophageal Reflux

    phase 2 small molecule completed

    1 trial

  9. Vonoprazan

    Phathom Pharmaceuticals

    Eosinophilic Esophagitis

    phase 2 small molecule active

    1 trial

  10. Vonsetamig

    Regeneron UK Limited

    Chronic Kidney Disease (CKD)

    phase 2 small molecule active

    1 trial

  11. Vortioxetine

    COGNITION THERAPEUTICS INC

    Post-COVID-19 Condition

    phase 2 small molecule completed

    1 trial

  12. Vortioxetine

    Takeda

    Binge Eating Disorder

    phase 2 small molecule completed

    1 trial

  13. Vortioxetine (IV)

    Takeda

    Depressive Disorder, Major

    phase 2 small molecule completed

    1 trial

  14. Vosoritide Injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Noonan Syndrome

    phase 2 small molecule active

    1 trial

  15. Vosoritide Injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Idiopathic Short Stature

    phase 2 small molecule active

    1 trial

  16. Voxzogo 0.56 mg powder and solvent for solution for injection, Voxzogo 1.2 mg powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Achondroplasia

    phase 2 small molecule active

    1 trial

  17. Voxzogo 0.56 mg powder and solvent for solution for injection, modified recombinant human C-type natriuretic peptide (rhCNP), Lyophilized powder for reconstitution, Voxzogo 1.2 mg powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Idiopathic Short Stature (ISS)

    phase 2 small molecule active

    1 trial

  18. Voxzogo 0.56 mg powder and solvent for solution for injection, powder and solvent for solution for injection

    BioMarin Pharmaceutical Australia Pty Ltd

    Hypochondroplasia

    phase 2 small molecule active

    1 trial

  19. Voxzogo 1.2 mg powder and solvent for solution for injection, Voxzogo 0.56 mg powder and solvent for solution for injection, modified recombinant human C-type natriuretic peptide (rhCNP)

    BioMarin Pharmaceutical Australia Pty Ltd

    Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome

    phase 2 small molecule active

    1 trial

  20. WBRT

    United Therapeutics Europe Ltd

    Bladder Cancer

    phase 2 other active

    1 trial

  21. WIDUS computer-delivered, indirect brief intervention

    BRIGHT MINDS BIOSCIENCES INC.

    Drug Abuse

    phase 2 other completed

    1 trial

  22. WJMSCs Vs. placebo

    The First People's Hospital of Lianyungang

    Ischemic Cardiomyopathy

    phase 2 mab active

    1 trial

  23. WSD0922-FU, WSD0922-FU

    Alphapharm Pty Ltd

    Non-Small Cell Lung Cancer

    phase 2 small molecule active

    1 trial

  24. WTX-330

    Werewolf Therapeutics

    Advanced or Metastatic Solid Tumors

    phase 2 small molecule active

    2 trials

  25. WVE-006

    Elan Pharma International

    Alpha-1 antitrypsin deficiency (AATD)

    phase 2 small molecule active

    1 trial

  26. Watchful waiting, RO7198457 (autogene cevumeran)

    BioNTech SE

    Stage II/Stage III rectal cancer or Stage II (high risk)/Stage III colon cancer

    phase 2 small molecule active

    1 trial

  27. WeCareAdvisor

    United Therapeutics Europe Ltd

    Dementia

    phase 2 other completed

    1 trial

  28. Wei Li Bai capsules

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Alzheimer Disease

    phase 2 small molecule terminated

    1 trial

  29. Whole cooked beans with rice meals

    United Therapeutics Europe Ltd

    Blood Glucose

    phase 2 other completed

    1 trial

  30. Will receive HH-009 injection 20 mg/kg, Q3W

    Huahui Health

    Advanced or Unresectable Hepatocellular Carcinoma (HCC)

    phase 2 small molecule active

    1 trial

  31. Within-Subject test of blinded study medication

    BRIGHT MINDS BIOSCIENCES INC.

    Low Back Pain, Recurrent

    phase 2 small molecule completed

    1 trial

  32. Within-subject test of blinded study medications

    BRIGHT MINDS BIOSCIENCES INC.

    Pain

    phase 2 small molecule completed

    1 trial

  33. Workshop

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    phase 2 other completed

    1 trial

  34. X-22 Smoking Cessation Product

    Century Therapeutics

    Smoking Cessation

    phase 2 small molecule completed

    1 trial

  35. X-82

    BRIGHT MINDS BIOSCIENCES INC.

    Age-Related Macular Degeneration (AMD)

    phase 2 small molecule terminated

    1 trial

  36. X-vivo 15 (serum-free growth medium manufactured under gmp and commercially available from Lonza)

    Biogen

    Peripherial arterial disease (PAD) & Chronic-Limb Threatening Ischemia (CLTI) patients who have not responded to standard pharmacological treatment or control of risk factors, and/or had a revascularisation with continued presence of smaller vessel (microvasculature) disease, and do not have the option of a revascularization treatment.

    phase 2 small molecule active

    1 trial

  37. X4P-001

    X4 Pharmaceuticals, Inc

    WHIM Syndrome

    phase 2 small molecule completed

    1 trial

  38. X4P-001

    X4 Pharmaceuticals, Inc

    Clear Cell Renal Cell Carcinoma

    phase 2 small molecule completed

    2 trials

  39. XB2001 or Placebo

    XBiotech Germany GmbH

    Pancreatic Cancer

    phase 2 mab active

    1 trial

  40. XELOX combined with Fruquintinib and Sintilimab

    The First People's Hospital of Lianyungang

    Gastric Cancer/Gastroesophageal Junction Adenocarcinoma

    phase 2 small molecule active

    1 trial

  41. XEN1101 10 mg

    Xenon Pharmaceuticals

    Major Depressive Disorder

    phase 2 small molecule completed

    1 trial

  42. XEOMIN 100 unités, poudre pour solution injectable, Placebo of Xeomin 100 UI, powder for injection

    Pari Pharma GmbH

    Degenerative shoulder rotator cuff tendinopathy

    phase 2 small molecule active

    1 trial

  43. XEOMIN, 100 unità, polvere per soluzione iniettabile

    Verona Pharma Ireland Limited

    multifocal spasticity of the upper and lower limb due to cerebral palsy

    phase 2 small molecule active

    1 trial

  44. XL092, XL092, XL092, XL092, Belzutifan

    Merck Sharp and Dohme

    Clear cell renal cell carcinoma

    phase 2 small molecule active

    1 trial

  45. XP19986 CR

    Indivior Pty Ltd

    GERD

    phase 2 small molecule completed

    1 trial

  46. XPF-001

    Xenon Pharmaceuticals

    Dental Pain

    phase 2 small molecule completed

    1 trial

  47. XPF-001

    Xenon Pharmaceuticals

    Primary Erythromelalgia

    phase 2 small molecule completed

    1 trial

  48. XPF-002

    Xenon Pharmaceuticals

    Primary Erythromelalgia

    phase 2 small molecule completed

    1 trial

Frequently asked questions

How many Phase II pipeline programs are in the directory?

7,238 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.